Published Date: 16 Feb 2023
Abbott has previously opposed legislation to test strips, but noted an 89% increase in fentanyl deaths in Texas over the past year.
Read Full NewsA yearly report from the American Association for Cancer Research lauds recent breakthroughs but warns on threatened federal funding changes.
A meta-analysis assesses the effect of nurse-led telenursing on the quality of life in women with breast cancer.
The 50-month follow-up of the ECHO trial underscores greater benefits with concurrent vs sequential addition of acalabrutinib to bendamustine and rituximab.
1.
Too Many Chest CTs for Incidental Lung Nodules?
2.
Major Shifts in Urothelial Cancer Care: Immunotherapy Redefines Standards
3.
Access to GLP-1 medications associated with a lower risk of colorectal cancer in people with type 2 diabetes: JAMA.
4.
Imetelstat for MDS-relateret anemia er godkendt af Food and Drug Administrations panel.
5.
Breast Cancer Incidence Rises in Asian American Women
1.
Tumor Neighborhoods and Therapy Response: Clinical and Mechanistic Insights
2.
Exercise Programming in Cancer Recovery: Evidence-Based Strategies for Clinical Practice
3.
Unlocking the Potential of Pirtobrutinib: A New Frontier in Cancer Treatment
4.
Modern Approaches to Detecting Residual Disease: Clinical Utility and Future Trends
5.
Unlocking the Potential of Immune Checkpoint Inhibitors: A Pioneering Case Series on the Role of Immunotherapy in Microsatellite-Instability-High Colorectal Cancer
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
2.
Navigating the Complexities of Ph Negative ALL - Part IX
3.
Understanding Iron Deficiency and Its Common Symptoms
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation